Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma

NCT07492628 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Bladder Cancer
Urothelial Carcinoma
Metastatic Urothelial Carcinoma
Locally Advanced Urothelial Carcinoma
Upper Tract Urothelial Carcinoma

Interventions

BIOLOGICAL: EB-DT-NK-UC101
DRUG: Cyclophosphamide
DRUG: Fludarabine

Sponsor

Beijing Biotech